Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

PRP may improve early ACL healing, but long-term effects are unclear.

Age and androgen levels significantly affect meibomian gland structure and function.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Bisphosphonate therapy can cause jawbone necrosis, so dental care is crucial before and during treatment.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Low vitamin D levels are linked to hair loss, and vitamin D might help treat it.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Azelaic acid helps with skin pigmentation issues, but its full effects are not completely understood.

The levels of zinc, vitamin D, ferritin, and selenium are different in people with androgenic alopecia compared to a control group.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

People with alopecia areata have higher levels of a heart disease marker in their blood.

High beta-hydroxybutyrate levels may worsen hair loss in alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Both treatments for alopecia areata showed similar modest effectiveness.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Actin filaments help stabilize and reshape cell membranes.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Linoleate deficiency in rats reduces growth and n-6 polyunsaturate accumulation, causing mild symptoms.